- Dosages
- Side effects in children
- Warnings & precautions in children
- Contra-indications in children
-
Interactions - PK
- Renal impairment
- References
Pharmacokinetics in children
No information is present at this moment.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
dose recommendation of formulary compared to licensed use (on-label versus off-label)
No information is present at this moment.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
Available formulations
No information is present at this moment.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
Dosages
| Severe itching |
|---|
|
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
Renal impaiment in children > 3 months
Adjustment in renal impairment as specified:
GFR 50-80 ml/min/1.73 m2
Dose adjustment is not requiredGFR 30-50 ml/min/1.73 m2
50% of the standard daily dose in 2 dosesGFR 10-30 ml/min/1.73 m2
50% of the standard daily dose in 2 dosesGFR < 10 ml/min/1.73 m2
Generalized recommendations cannot be given.A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here
Side effects in children
Young children are more likely to develop side effects related to the CNS (such as convulsions).
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here
Contra-indications
No information available on specific contra indications in children.
The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here
Warnings & precautions in children
Very strongly sedating.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
Interactions
The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
| Benzodiazepine derivatives | ||
|---|---|---|
| N05BA12 | ||
| N05BA08 | ||
| N05BA09 | ||
| N05BA01 | ||
| N05BA06 | ||
| N05BA04 | ||
| Azaspirodecanedione derivatives | ||
|---|---|---|
| N05BE01 | ||
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
References
- UCB Pharma BV, SPC Atarax (RVG 01218), www.cbg-meb.nl, Geraadpleegd 03 november 2010, http://db.cbg-meb.nl/IB-teksten/h01218.pdf
- UCB Pharma BV, SmPC Hydroxyzine-2HCL 10 & 25 mg filmomhulde tabletten (RVG 50109) 06 jan 2023, www.geneesmiddelinformatiebank.nl
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
Changes
Changes
